Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCARDIOVASCULAR

Sphingosine 1-Phosphate Inhibits Nitric Oxide Production Induced by Interleukin-1β in Rat Vascular Smooth Muscle Cells

Takuji Machida, Yukihiro Hamaya, Sachiko Izumi, Yumika Hamaya, Kenji Iizuka, Yasuyuki Igarashi, Masaru Minami, Roberto Levi and Masahiko Hirafuji
Journal of Pharmacology and Experimental Therapeutics April 2008, 325 (1) 200-209; DOI: https://doi.org/10.1124/jpet.107.127290
Takuji Machida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yukihiro Hamaya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sachiko Izumi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yumika Hamaya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenji Iizuka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasuyuki Igarashi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masaru Minami
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberto Levi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masahiko Hirafuji
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Sphingosine 1-phosphate (S1P) is a lipid mediator that exerts potent and diverse biological effects on several cardiovascular cells. We investigated the effect of S1P on interleukin (IL)-1β-induced nitric oxide (NO) production and inducible NO synthase (iNOS) expression in rat vascular smooth muscle cells (VSMCs). S1P inhibited NO production at concentrations higher than 0.1 μM; this was associated with the inhibition of iNOS protein and mRNA expression. S1P also inhibited IL-1β-induced GTP cyclohydrolase I (GTPCH) mRNA expression. Pertussis toxin (PTX) partially attenuated the inhibitory effects of S1P on NO production and iNOS protein induction, whereas it completely blocked the inhibitory effects on iNOS and GTPCH mRNA expression. S1P inhibited iNOS expression in Ca2+-depleted conditions; PTX did not modify this effect. The Rho kinase inhibitor Y 27632 partially but significantly attenuated the inhibitory effect of S1P on iNOS expression in Ca2+-depleted condition but did not affect it in the presence of Ca2+. S1P significantly inhibited IL-1β-induced persistent activation of extracellular signal-regulated kinase (ERK) but had no effect in Ca2+-depleted conditions. Thus, S1P inhibits IL-1β induction of NO production and iNOS expression in rat VSMCs through multiple mechanisms involving both PTX-sensitive and -insensitive G proteins coupled to S1P receptors. Furthermore, Ca2+-dependent ERK inhibition and Ca2+-independent Rho kinase activation might be involved in the inhibitory mechanism of iNOS expression. Through its action on NO production by VSMCs, S1P may play an important role in the progression of local vascular injury associated with thrombosis, atherosclerosis, and hypertension.

Footnotes

  • This study was supported in part by The High Technology Research Program from the Ministry of Education, Science, Sports and Culture of Japan and by The Akiyama Foundation. R.L. was supported by National Institutes of Health Grants HL34215, HL73400, HL47073, and HL46403.

  • Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.

  • doi:10.1124/jpet.107.127290.

  • ABBREVIATIONS: NO, nitric oxide; NOS, nitric-oxide synthase; VSMC, vascular smooth muscle cell; iNOS, inducible nitric-oxide synthase; IL, interleukin; ERK, extracellular signal-regulated kinase; S1P, sphingosine 1-phosphate; PTX, pertussis toxin; MAPK, mitogen-activated protein kinase; eNOS, endothelial nitric-oxide synthase; nNOS, neuronal nitric-oxide synthase; GTPCH, GTP cyclohydrolase I; RT, reverse transcription; PCR, polymerase chain reaction; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; BH4, tetrahydrobiopterin; BAPTA-AM, 1,2-bis-(o-aminophenoxy)-ethane-N,N,N′,N′-tetraacetic acid tetraacetoxy-methyl ester; PD 98059, 2′-amino-3′-methoxyflavone; SB 203580, 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)5-(4-pyridyl)1H-imidazole; GF 109203X, 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)-maleimide; Y 27632, (R)-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide, 2HCl; rottlerin, 1-[6-[(3-acetyl-2,4,6-trihydroxy-5-methylphenyl)methyl]-5,7-dihydroxy-2,2-dimethyl-2H-1-benzopyran-8-yl]-3-phenyl-2-propen-1-one; 1400W, N-([3-(aminomethyl)phenyl]methyl)ethanimidamide dihydrochloride; PKC, protein kinase C; p-ERK, phosphorylated ERK; t-ERK, total ERK.

    • Received June 14, 2007.
    • Accepted December 28, 2007.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 377 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 377, Issue 2
1 May 2021
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Sphingosine 1-Phosphate Inhibits Nitric Oxide Production Induced by Interleukin-1β in Rat Vascular Smooth Muscle Cells
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCARDIOVASCULAR

Sphingosine 1-Phosphate Inhibits Nitric Oxide Production Induced by Interleukin-1β in Rat Vascular Smooth Muscle Cells

Takuji Machida, Yukihiro Hamaya, Sachiko Izumi, Yumika Hamaya, Kenji Iizuka, Yasuyuki Igarashi, Masaru Minami, Roberto Levi and Masahiko Hirafuji
Journal of Pharmacology and Experimental Therapeutics April 1, 2008, 325 (1) 200-209; DOI: https://doi.org/10.1124/jpet.107.127290

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleCARDIOVASCULAR

Sphingosine 1-Phosphate Inhibits Nitric Oxide Production Induced by Interleukin-1β in Rat Vascular Smooth Muscle Cells

Takuji Machida, Yukihiro Hamaya, Sachiko Izumi, Yumika Hamaya, Kenji Iizuka, Yasuyuki Igarashi, Masaru Minami, Roberto Levi and Masahiko Hirafuji
Journal of Pharmacology and Experimental Therapeutics April 1, 2008, 325 (1) 200-209; DOI: https://doi.org/10.1124/jpet.107.127290
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Improved Assessment of Cardiovascular Safety Data
  • G6PD, DNA methylation, and PAH
  • Effect of Acetate on HR, Blood Pressure, and Cardiac Contractility
Show more Cardiovascular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics